from django.shortcuts import render,HttpResponse,redirect
from django.utils.safestring import mark_safe
from entreprise_questions.models import EQuestions,EQuestions1,EQuestions2,EQuestions3,EQuestions4,EQuestions5,\
EQuestions6,EQuestions7,EQuestions8,EQuestions9,EQuestions10,EQuestions11,EQuestions12,EQuestions13,EQuestions14,DocumentsPrepared
from iquestions.models import IQuestions1,IQuestions2
from registration.models import User,UserDetail,UserDetail2
from connections.models import Match_Data
from datetime import datetime
from django.contrib.auth.decorators import login_required
from ..models import Capital_Matches,Matches_Purchased,Letter_Response,Purchases

def privateequitysecuritiessafesimpleagreementfutureequity(request):
    name = EQuestions2.objects.get(user=request.user).Business_Name
    introduction = mark_safe("""
    <p><center><b><u>Definition of Capital Market: Private Equity Securities</b></u><br>
    Capital Type: SAFE  Simple Agreement Future Equity </center></p>
    <p><b><u>Introduction</u></b><br>
    Private equity securities refer to investment instruments used by private companies to raise capital from investors without accessing public markets. One widely used instrument within private equity financing is the Simple Agreement for Future Equity (SAFE). SAFE agreements allow startups to receive funding today in exchange for the right of investors to receive equity at a later date, typically upon a priced equity financing round or other triggering events. {n} fits that definition.
    Originally introduced by Y Combinator in 2013, SAFE agreements were designed to simplify early-stage fundraising by reducing legal complexity, transaction costs, and negotiation time. Unlike traditional equity or debt instruments, SAFEs do not accrue interest, have no maturity date, and do not require immediate valuation of the company. According to Y Combinator, SAFEs have become a dominant financing mechanism for seed-stage startups globally due to their flexibility and founder-friendly structure.
    </p>
    <p><b><u>Definition of Capital Type</b></u><br>
    1. A SAFE (Simple Agreement for Future Equity) is a contractual agreement between a startup and an investor in which the investor provides capital in exchange for the right to receive equity in the company at a future date, subject to specific triggering events such as a priced equity round, acquisition, or initial public offering (IPO). SAFEs are not debt instruments and therefore do not require repayment, interest payments, or collateral. Instead, they convert into equity based on predetermined terms, such as valuation caps or discount rates (Y Combinator, n.d.).<br><br>
    2. SAFE agreements are best suited for early-stage startups, particularly pre-revenue or seed-stage companies that lack sufficient financial history to support traditional valuation or debt financing. Technology startups, innovative product-based ventures, and high-growth potential businesses commonly use SAFEs due to their speed and simplicity. Companies operating in uncertain or rapidly evolving markets benefit from SAFEs because they allow founders to delay valuation discussions until more market traction is achieved. However, SAFEs are less suitable for stable, low-growth businesses or ventures seeking immediate clarity on ownership structure (NVCA, 2023).<br><br>
    3. The SAFE was introduced by Y Combinator in 2013 as an alternative to convertible notes, which often created complexity due to interest rates and maturity dates. The objective was to create a more straightforward, equity-oriented instrument that aligned founder and investor incentives. Since its introduction, SAFEs have been widely adopted across startup ecosystems in the United States, Europe, and emerging markets. According to the National Venture Capital Association, SAFEs now account for a significant portion of seed-stage financing transactions, particularly in accelerator-backed startups (NVCA, 2022).<br><br>
    4. Despite their advantages, SAFEs pose risks for both founders and investors. For founders, excessive use of SAFEs can lead to significant equity dilution during future financing rounds. Additionally, because SAFEs do not appear as debt, they may obscure a company's true capitalization structure. For investors, SAFEs provide limited downside protection, as they do not guarantee equity ownership unless a triggering event occurs. If the startup fails or never raises a priced round, the investment may result in a total loss. Legal enforceability and jurisdiction-specific treatment of SAFEs may also vary (Harvard Law School Forum, 2021).<br><br>
    5. From a legal and financial perspective, a SAFE is classified as a contingent equity instrument rather than a security with fixed claims. It grants investors conditional rights to future shares without conferring voting rights, dividends, or liquidation preferences at the time of issuance. Until a conversion event occurs, SAFE holders are not considered shareholders and therefore have limited governance influence over the company. This structure simplifies early-stage fundraising but shifts much of the investment risk to investors, who rely heavily on the startup's ability to reach a qualifying equity-financing milestone (U.S. Securities and Exchange Commission [SEC], 2020).
    </p>
    <p><u><b>References</u></b><br>
    Y Combinator. (n.d.). SAFE: Simple Agreement for Future Equity. https://www.ycombinator.com/documents<br>
    National Venture Capital Association (NVCA). (2022). Seed-stage financing trends. https://nvca.org<br>
    National Venture Capital Association (NVCA). (2023). Model legal documents and startup financing. https://nvca.org<br>
    Harvard Law School Forum on Corporate Governance. (2021). Convertible instruments and SAFE agreements. https://corpgov.law.harvard.edu<br>
    U.S. Securities and Exchange Commission (SEC). (2020). Framework for "Investment Contract" Analysis of Digital Assets. https://www.sec.gov/about/divisions-offices/division-corporation-finance/framework-investment-contract-analysis-digital-assets
    </p>
    <p><b><u>Legal Qualification Requirements</b></u><br>
    • Startup must be a private company<br>
    • Valid legal incorporation<br>
    • Execution of SAFE agreement under applicable jurisdiction<br>
    • Disclosure of SAFE terms to future investors<br>
    • Compliance with securities regulations<br>
    • Maintenance of updated capitalization table
    </p>
    <p><b><u>Supporting Document List</b></u><br>
    • SAFE agreement document<br>
    • Term sheet outlining valuation cap and discount<br>
    • Investor subscription records<br>
    • Proof of fund transfer<br>
    • Updated capitalization table<br>
    • Corporate governance documents<br>
    • Legal compliance and disclosure records
    </p>
    """)
    introduction = mark_safe(introduction.format(n=name))
    context = {'introduction':introduction,}
    return render(request,'detail.html',context)

def privateequitysecuritiessafesimpleagreementfutureequityfaq(request):
    introduction = mark_safe("""
    <p><b><center>Capital Market: Private Equity Securities<br>
    SAFE  Simple Agreement Future Equity</center></b></p>
    <p><center><u><b>Frequently Asked Question</u></b></center></p>
    <p><u><b>1. What is a SAFE (Simple Agreement for Future Equity)?</u></b><br>
    • Answer: A SAFE is a financial instrument that allows investors to provide funding to a startup in exchange for future equity, typically during the company's next priced funding round. It is not a loan, does not accrue interest, and does not have a maturity date.
    </p>
    <p><u><b>2. How does SAFE differ from traditional equity financing?</u></b><br>
    • Answer: Unlike traditional equity investments, a SAFE does not immediately dilute ownership. The investor receives the right to equity at a future financing event, usually at a discounted price or with a valuation cap, based on pre-agreed terms.
    </p>
    <p><u><b>3. How does SAFE differ from convertible notes?</u></b><br>
    • Answer: SAFEs are similar to convertible notes but do not carry debt features such as interest or repayment obligations. Convertible notes are debt instruments that convert into equity, whereas SAFEs are purely equity-based agreements with no loan characteristics.
    </p>
    <p><u><b>4. What types of startups are best suited for SAFE financing?</u></b><br>
    • Answer: SAFEs are best suited for early-stage startups seeking quick, flexible capital without the administrative complexity of priced equity rounds. They are common in technology, software, and high-growth ventures preparing for seed or Series A rounds.
    </p>
    <p><u><b>5. How much funding can be raised through a SAFE?</u></b><br>
    • Answer: Funding amounts vary and are negotiated between the startup and investors. There is no minimum or maximum mandated by law, but typical seed-stage SAFEs range from $25,000 to several million dollars, depending on investor appetite.
    </p>
    <p><u><b>6. How quickly can startups access capital through a SAFE?</u></b><br>
    • Answer: SAFEs are designed to be fast and straightforward. Once terms are agreed and executed, funds can often be transferred in days to weeks, making them faster than traditional priced equity rounds.
    </p>
    <p><u><b>7. Does SAFE require giving up equity immediately?</u></b><br>
    • Answer: No. Equity is only issued at a future equity financing event. Until that time, ownership is not diluted, though SAFE holders have contractual rights to future shares.
    </p>
    <p><u><b>8. How is valuation determined in a SAFE?</u></b><br>
    • Answer: SAFEs often include a valuation cap or discount rate to determine the conversion price at the next priced round. This ensures early investors are rewarded for the higher risk taken at the initial investment stage.
    </p>
    <p><u><b>9. Are there risks associated with SAFEs?</u></b><br>
    • Answer: Key risks include: No guarantee of conversion if a future round never occurs. Potential dilution if multiple SAFEs convert simultaneously. Investors have limited control or governance rights until conversion.
    </p>
    <p><u><b>10. Can SAFE investors participate in other funding rounds?</u></b><br>
    • Answer: SAFE holders typically convert in the next equity round. They may negotiate pro-rata rights to maintain ownership percentages but generally cannot invest outside the SAFE without a separate agreement.
    </p>
    <p><u><b>11. What are the benefits of using a SAFE for startups?</u></b><br>
    • Answer: Benefits include: Quick and low-cost fundraising. No debt or repayment obligations. Delayed equity dilution. Simplified legal and administrative requirements.
    </p>
    <p><u><b>12. What are the benefits of using a SAFE for investors?</u></b><br>
    • Answer: Investors gain: Potential for high return if the startup grows. Early access to high-potential startups. Pre-agreed terms that protect downside risk through valuation caps or discounts.
    </p>
    <p><u><b>13. Can SAFEs be combined with other funding sources?</u></b><br>
    • Answer: Yes. SAFEs are commonly used alongside grants, accelerators, angel investment, or traditional equity rounds. They are flexible and can complement other financing strategies.
    </p>
    <p><u><b>14. How do SAFEs compare to venture capital?</u></b><br>
    • Answer: SAFEs are typically earlier-stage and simpler than VC funding. VCs often negotiate priced equity rounds with board seats and control provisions, whereas SAFEs are contractual agreements designed for speed and simplicity.
    </p>
    <p><u><b>15. How can startups improve their chances of SAFE investment?</u></b><br>
    • Answer: Startups should have a clear business model, demonstrate early traction or product validation, maintain a strong founding team, and prepare transparent financials. Clear terms and a compelling pitch increase investor confidence.
    </p>
    """)
    context = {'introduction':introduction,}
    return render(request,'detail.html',context)

def privateequitysecuritiessafesimpleagreementfutureequitytwelve(request):
    name = EQuestions2.objects.get(user=request.user).Business_Name
    entity = EQuestions2.objects.get(user=request.user).Selected_Option
    stage = EQuestions1.objects.get(user=request.user).Selected_Option
    preraise = EQuestions3.objects.get(user=request.user).Selected_Option
    premarket = EQuestions4.objects.get(user=request.user).Selected_Options
    raisegoal = EQuestions5.objects.get(user=request.user).Selected_Option
    useoffund = EQuestions7.objects.get(user=request.user).Selected_Options
    enterprisecost = EQuestions8.objects.get(user=request.user).Selected_Option2
    tranch = EQuestions6.objects.get(user=request.user).Selected_Option
    rounds = EQuestions6.objects.get(user=request.user).Selected_Options
    upfrontcost = EQuestions.objects.get(user=request.user).Selected_Option
    upfronttime = EQuestions.objects.get(user=request.user).Selected_Option2
    introduction = """
    <center><p><b><u>FINFIRE CAPITAL MATCH REPORT FOR: Private Equity Securities</b></u><br>
    Capital Type: SAFE  Simple Agreement Future Equity</p></center>
    <p><b><u>1 – Stage of Development Assessment</b></u><br>
    SAFE instruments are best suited for early-stage startups, typically at the pre-seed to early seed stage, where the company has strong growth potential but lacks a clear valuation. SAFEs allow startups to raise capital quickly while deferring valuation discussions to a later equity round. {stage} aligns with SAFE financing.
    </p>
    <p><b><u>2 – Entity Type Assessment</b></u><br>
    SAFEs are most compatible with C-Corporations, as they are designed to convert into preferred equity during a priced round. While some startups attempt to use SAFEs in LLCs, this is less common and legally complex. Investor preference strongly favors C-Corp structures. {{entity}} is {{entity}} suitable for SAFEs.
    </p>
    <p><b><u>3 – Pre-Capital Assessment</b></u><br>
    Startups raising capital through SAFEs typically have limited prior funding, such as founder bootstrapping, grants, or small angel investments. SAFEs are often used as the first external equity-like capital before a priced seed or Series A round. {{preraise}} reflects {{preraise}} typical SAFE use cases.
    </p>
    <p><b><u>4 – Pre-Capital Market Type Assessment</b></u><br>
    SAFE financing operates within private equity markets and is commonly used by angel investors, early-stage funds, and accelerators. Existing SAFEs or convertible instruments must be carefully managed to avoid excessive dilution or cap table complexity. {{premarket}} reflects {{premarket}} market positioning.
    </p>
    <p><b><u>5 – Planned Total Capital to Raise Assessment</b></u><br>
    SAFE rounds usually involve modest capital raises, often ranging from $50,000 to several million dollars, depending on startup traction and investor appetite. They are designed to bridge the company to a future priced equity round. {{raisegoal}} aligns with SAFE parameters.
    </p>
    <p><b><u>6 – Capital Round Assessment</b></u><br>
    SAFE financing aligns with the pre-seed and seed fundraising stages. It is not intended to replace a priced equity round but to delay valuation until the business reaches clearer milestones. {{tranch}} represents {{tranch}} structure.
    </p>
    <p><b><u>7 – Tranche Schedule Assessment</b></u><br>
    SAFEs are typically raised in a single tranche, though startups may issue multiple SAFEs over time with different investors. Conversion occurs later, usually upon a qualified financing event, acquisition, or IPO. {{rounds}} reflects {{rounds}} approach.
    </p>
    <p><b><u>8 – Use of Funds Assessment</b></u><br>
    Funds raised through SAFEs are generally flexible and used for product and technology development, market validation and early customer acquisition, hiring key early team members, and operating and administrative expenses. There are usually no investor-imposed spending restrictions, but funds should support growth toward the next financing round. {{useoffund}} represents {{useoffund}} typical uses.
    </p>
    <p><b><u>9 – Risk Assessment</b></u><br>
    Risk is high for investors and founders. Investors face uncertainty around conversion timing and valuation, while founders risk significant dilution if future valuations are lower than expected. SAFEs also provide no repayment obligation, increasing investor exposure.
    </p>
    <p><b><u>10 – Capital Cost Assessment</b></u><br>
    The cost of capital is uncertain and deferred. SAFEs do not accrue interest or have maturity dates (in most modern forms), but conversion terms such as valuation caps and discounts determine the eventual equity cost. {{enterprisecost}} reflects {{enterprisecost}} cost profile.
    </p>
    <p><b><u>11 – Upfront Cost Assessment</b></u><br>
    Upfront costs are low, mainly limited to legal documentation and compliance. SAFEs are simpler and cheaper to execute than priced equity rounds or convertible notes. {{upfrontcost}} is {{upfrontcost}} typical.
    </p>
    <p><b><u>12 – Timing to Capital Assessment</b></u><br>
    SAFE financing allows for fast capital deployment, often within days to weeks, as it avoids valuation negotiations and complex underwriting processes. {{upfronttime}} reflects {{upfronttime}} expected timeline.
    </p>
    """
    introduction = mark_safe(introduction.format(rounds=rounds,entity=entity,stage=stage,n=name,preraise=preraise,premarket=premarket,raisegoal=raisegoal,useoffund=useoffund,enterprisecost=enterprisecost,tranch=tranch,upfrontcost=upfrontcost,upfronttime=upfronttime))
    context = {'introduction':introduction,}
    return render(request,'detail.html',context)
